Side Table: The 340B Dilemma: Who Really Benefits? — The Doctors’ Lounge

📌 Why Listen
Explore the complexities of the 340B program, its impact on healthcare systems, and the implications for both hospitals and independent clinicians. Understand the need for transparency and potential reforms to align the program with its original goals.

👥 Co-Hosts

Anthony DiGiorgio, DO, MHA – Neurosurgeon, UCSF; health policy researcher
Anish Koka, MD – Cardiologist, Philadelphia; healthcare policy commentator

📌 Episode Overview

In this episode, the hosts delve into the complexities of the 340B program, exploring its origins, current state, and the implications for hospitals and independent clinicians. They discuss how the program, initially intended to support hospitals serving low-income patients, has evolved into a significant revenue stream for large health systems, often at the expense of independent practices and without clear benefits to the intended beneficiaries. The conversation also touches on potential reforms and the need for greater transparency and accountability.

Episode Links
https://www.healthaffairs.org/content/forefront/340b-drug-pricing-program-capped-safety-net-grant

https://jamanetwork.com/journals/jama-health-forum/fullarticle/2821579

💬 Notable Quotes